Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Tirzepatide × Other × Clear all

Phase

Phase EARLY_PHASE1 2 Phase 2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Gastrointestinal 1

Conditions

Obesity 1 Colorectal Neoplasms 1

Interventions

Metformin 2 rosiglitazone-metformin combination 1 mirabegron 1 lorcaserin 1 exemestane 1 atezolizumab 1 Traumeel S 1 Tirzepatide 1 TIC10 compound 1 Sodium Chloride 1 Rosiglitazone 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Melphalan 1 Leflunomide 1 Hydroquinones 1 Fish Oils 1 Fibroblast Growth Factor 7 1 Drug Therapy 1 Docosahexaenoic Acids 1 Cisplatin 1 Cholestyramine Resin 1 CBLB502 1 Ascorbic Acid 1 Acupuncture Therapy 1 ART123 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07095517 2026-02-27

PROSPECT

Massachusetts General Hospital

Phase 1 Recruiting

GastrointestinalOther

Obesity, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡